文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 医药卫生 > 基础医学 > In vitro target validation and in vivo efficacy of p38 MAP kinase inhibition in established chronic
侵权投诉

In vitro target validation and in vivo efficacy of p38 MAP kinase inhibition in established chronic

In vitro target validation and in vivo efficacy of p38 MAP kinase inhibition in established chronic collagen-induced arthritis model a pre-clinical study

recombinant from Invitrogen Ltd, Paisley, UK.interleukin IL-1β was Induction and monitoring of CIA

Bovine from type II murine bovine collagen was extracted from mouse sternums (6). Collagen was type II articular collagen cartilage was puri ed and dissolved in 0.05M acetic acid and emul-si ed with an equal volume of Freund’s complete adjuvant (CFA; Difco Becton Dickinson, Cowley, Oxford, UK).

Mice DBA/1 (H-2q) purchased from Harlan used in this study were male UK Limited (Bicester, Oxon, UK). An-imals were housed in individual venti-lated cycle and were fed standard laboratory cages over a 12-hour light/dark chow work Of ce project licence PPL no: 70/5446 was and conducted water ad under libitumthe . Animal Home Pathogenesis and therapy for RAthe operatives of the Animals (Scientif- under ic Procedures) Act 1986.

For induction of acute CIA, 10-12 week old mal mice 100injection received at the a base single of intrader- ed in CFA, containing paraf n oil, and μg bovine type II collagen the emulsi-tail of lyophilised sis Cowley, H37 Ra Mycobacterium (Difco Becton Dickinson, tuberculo-cal oedema and/or erythema involving any signs Oxon, of arthritis UK). were The assessed rst clini-by of the four paws. Onset of disease was observed administration, as previously described from 2 weeks after collagen (3, 7-14).

For the induction of chronic relapsing arthritis, immunised with 10010-12 week old mice type II collagen emulsi ed in CFA by μg of homologous were intradermal injection at the base of the tail. On day 14 after immunisation the mice were boosted with 100mologous μg of ho-clinical signs of arthritis were assessed type II collagen. The rst as for acute CIA, with onset of disease occurring type Freund’s II collagen from 2 boost weeks in after murine mary immunisation), as previously de-adjuvant (4 weeks incomplete after pri-scribed (3, 4, 15).

The treated, mice or inhibitor-treated were randomised into un-(1% DMSO plus 99% methyl cellulose)

GSK678361) and vehicle-treated (GW856553X Following onset of arthritis, mice were treated with GW856553X (0.8mg/kg, 4mg/kg, 10mg/kg daily Fig. 1. GW856553X reduces acute CIA.

or 20mg/kg daily), vehicle alone or left untreated (n=5-8 per group). (over a 10 day period, and data are expressed as mean ± SEM. Statistical analysis was carried out using a) Clinical score was assessed a 2-way ANOVwere sacri ced and paws were sectioned for histological evaluation. Representative sections are shown A versus vehicle-treated mice: ***p<0.001. At the end of the study (day 10), animals as follows: (10mg/kg GW856553X, (b) untreated, (in a blinded fashion for pannus formation, synovitis, and bone and cartilage erosion. Paws were as-gc) 20mg/kg GW856553X. () vehicle-treated, (d) 0.8mg/kg GW856553X, (h) Haematoxylin and eosin sections were scored e) 4mg/kg GW856553X, (f) signed one of three grades: 0=normal; 1=moderate synovitis with some loss of cartilage; 2=extensive synovial histological score (metatarsal, tibia-tarsus, proximal interphalangeal and distal interphalangeal joints). hyperplasia, destruction of cartilage and some bone erosions. Results are mean (± SEM) Statistical analysis was carried out by 1-way ANOVA versus vehicle-treated mice: ***p<0.001.

groups, at the onset of the disease. Treat-ments in ammation; 1: slight oedema or ery-neally (i.p.), from the day of arthritis on-were administered intra-perito-thema; set. Paw swelling was measured with 0-involving the entire paw; 3: pronounced 2: pervading oedema/erythema 10 mm callipers (Kroeplin, Schluchern, oedema Germany). pacitated limb mobility.

and erythema leading to inca-monitored daily and each limb was as-In both models, mice were signed Histological analysis

normal paws and no clinical features of

a clinical score as follows: 0: Hind tem and paws xed were in 4%. removed Fixed

In vitro target validation and in vivo efficacy of p38 MAP kinase inhibition in established chronic

specimens

post-mor-178

上一页第3页

你可能喜欢

热门文档

相关文档

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email